Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2000
05/18/2000WO2000028092A1 Method for generating gene expression profiles
05/18/2000WO2000028082A1 Process for synthesizing nucleic acid
05/18/2000WO2000028080A2 Methods, software and apparati for identifying genomic regions harboring a gene associated with a detectable trait
05/18/2000WO2000028079A2 Genetic variation associated with aplastic anemia, and diagnosis and therapy based thereon
05/18/2000WO2000028078A1 Use of dna identification techniques for the determination of genetic material of cocoa in fermented or roasted beans and chocolate
05/18/2000WO2000028075A1 Bacillus strain and assay methods
05/18/2000WO2000028066A1 Host cells expressing recombinant human erythropoietin
05/18/2000WO2000028065A1 Method for the production of fvii
05/18/2000WO2000028062A1 Novel system for regulating transgene expression
05/18/2000WO2000028061A2 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
05/18/2000WO2000028060A2 Cells for the production of helper dependent adenoviral vectors
05/18/2000WO2000028059A1 Adenovirus-mediated gene therapy
05/18/2000WO2000028058A2 Transcriptional activator lec1 nucleic acids, polypeptides and their uses
05/18/2000WO2000028057A2 PLANT AMINOACYL-tRNA SYNTHETASES
05/18/2000WO2000028056A2 HYPERSENSITIVE RESPONSE ELICITOR FROM $i(AGROBACTERIUM VITIS)
05/18/2000WO2000028055A2 Hypersensitive response elicitor-induced stress resistance
05/18/2000WO2000028054A2 Plant proteins that interact with nuclear matrix proteins and function as transcriptional activators
05/18/2000WO2000028053A2 Plant glutamine amidotransferase homologs
05/18/2000WO2000028052A2 Nucleic acid molecules from rice encoding an r1 protein and their use for the production of modified starch
05/18/2000WO2000028051A1 Method to control gene expression in bacteria, namely rhizobiaceae, to improve root nodule development, nitrogen fixation and plant biomass production
05/18/2000WO2000028050A1 Method for expressing recombinant proteins using the effect of stress and stress response mechanisms in the presence of compatible solutes
05/18/2000WO2000028049A1 A high-stability prokaryotic plasmid vector system
05/18/2000WO2000028048A1 Novel plasmids for use in medicine and method of producing same
05/18/2000WO2000028047A1 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use
05/18/2000WO2000028046A1 Coffea arabica mannanase
05/18/2000WO2000028045A2 Human hydrolase proteins
05/18/2000WO2000028044A1 Polypeptides having lysophospholipase activity and nucleic acids encoding same
05/18/2000WO2000028043A2 Polypeptides having lactonohydrolase activity and nucleic acids encoding same
05/18/2000WO2000028042A1 Use of an inducible gene for the enzyme cyclooxygenase to lower intraocular pressure
05/18/2000WO2000028041A1 Delivery of superoxide dismutase to neuronal cells
05/18/2000WO2000028040A2 Cloning of rhadinovirus genome and methods for its use
05/18/2000WO2000028039A2 Identification of senv genotypes
05/18/2000WO2000028038A2 Virulence genes and proteins, and their use
05/18/2000WO2000028037A1 CATFIIIA CANDIDA ALBICANS tfIIIA GENE (CatfIIIA) AND THE CODED CATFIIIA PROTEIN
05/18/2000WO2000028036A2 Disease resistance factors
05/18/2000WO2000028035A1 CHEMOKINE β-7
05/18/2000WO2000028034A2 Cytokine signal regulators
05/18/2000WO2000028033A2 Nucleic acids and polypeptides having altered expression in the t84 gut barrier model
05/18/2000WO2000028032A2 Human cell surface receptor proteins
05/18/2000WO2000028031A2 Mitogenic regulators
05/18/2000WO2000028030A1 Human secretory protein-61
05/18/2000WO2000028029A2 Cell surface glycoproteins
05/18/2000WO2000028028A1 G-protein coupled receptors, homologous to ebv-induced gpcr 2 (ebi-2). methods to seek for ligands thereof
05/18/2000WO2000028027A2 Corticosteroid synthesis-associated genes
05/18/2000WO2000028026A2 Gene expression modulated by opiate administration and withdrawal
05/18/2000WO2000028025A1 Pholasin
05/18/2000WO2000028024A1 htfIIIA HUMAN GENE AND CODED hTFIIIA PROTEIN
05/18/2000WO2000028023A2 Ischaemia/reperfusion-inducible dna's and proteins
05/18/2000WO2000028022A1 Pge synthase and methods and means for modulating its activity
05/18/2000WO2000028021A1 A factor viii-polypeptide with factor viii:c-activity
05/18/2000WO2000028020A2 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor
05/18/2000WO2000028019A2 Antisense oligomer
05/18/2000WO2000028017A1 Modified phosphoenolpyruvate carboxylase for improvement and optimization of plant phenotypes
05/18/2000WO2000028016A1 T cells specific for target antigens and methods and vaccines based thereon
05/18/2000WO2000028015A1 Mutagenesis method
05/18/2000WO2000028014A2 Plastid transformation of solanaceous plants
05/18/2000WO2000028012A2 THE USE OF β-GLUCOSIDASE TO ENHANCE DISEASE RESISTANCE AND RESISTANCE TO INSECTS IN CROP PLANTS
05/18/2000WO2000028011A2 Fk506-based regulation of biological events
05/18/2000WO2000028010A2 The genetic determination of genes and its use for the prophylaxis and therapy of diseases
05/18/2000WO2000028008A1 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase
05/18/2000WO2000028006A2 Plant nadp-specific glutamate dehydrogenase
05/18/2000WO2000028005A1 Nucleic acids encoding taxus geranylgeranyl diphosphate synthase, and methods of use
05/18/2000WO2000028004A1 Virus vectors and methods of making and administering the same
05/18/2000WO2000028003A1 Avipox vector coding an hiv antigen and a cytokine
05/18/2000WO2000028002A1 Dna molecules encoding the melanocortin 5 receptor protein from rhesus monkey
05/18/2000WO2000028001A1 Modified exosomes and uses
05/18/2000WO2000027997A1 Method for the massive culture of cells producing recombinant human erythropoietin
05/18/2000WO2000027995A1 Embryonic stem cells
05/18/2000WO2000027994A2 Chlamydia pneumoniae genome sequence
05/18/2000WO2000027883A2 A method of treating tumors using fas-induced apoptosis
05/18/2000WO2000027879A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof
05/18/2000WO2000027878A1 Screening system for zinc finger polypeptides for a desired binding ability
05/18/2000WO2000027874A2 Nucleic acids encoding transferrin receptor-like proteins and products related thereto
05/18/2000WO2000027870A1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
05/18/2000WO2000027868A2 Connective tissue growth factor (ctgf) and methods of use
05/18/2000WO2000027864A1 CHROMOSOME 17p-LINKED PROSTATE CANCER SUSCEPTIBILITY GENE
05/18/2000WO2000027863A1 Dna molecules encoding the melanocortin 4 receptor protein from rhesus monkey
05/18/2000WO2000027862A1 Dna molecules encoding the melanocortin 3 receptor protein from rhesus monkey
05/18/2000WO2000027860A2 Polynucleotide crosslinking agents
05/18/2000WO2000027858A1 Antisense oligonucleotides which inhibit telomerase's activity and their uses
05/18/2000WO2000027809A1 Method for preparing methionine
05/18/2000WO2000027795A1 Transfection reagents
05/18/2000WO2000027521A1 A method for reproducing molecular arrays
05/18/2000WO2000027437A2 Polymer grafting by polysaccharide synthases
05/18/2000WO2000027432A1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS
05/18/2000WO2000027429A2 Vaccine against papillomatous digital dermatitis (pdd)
05/18/2000WO2000027425A2 Pharmaceutical preparation containing a receptor-antagonist for treating blood-clotting disorders
05/18/2000WO2000027422A2 Methods and compositions for treating or preventing peripheral neuropathies
05/18/2000WO2000027409A1 Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells
05/18/2000WO2000027361A1 Stabilized nucleic acid compositions and methods of preparation and use thereof
05/18/2000WO2000027340A2 USE OF t-RNA AND FRAGMENTS FOR INHIBITING ANGIOGENESIS AND COMPOSITIONS THEREOF
05/18/2000WO2000027198A1 Retroviral vectors encoding interferon alpha and uses thereof
05/18/2000WO2000027186A1 Adult t cell leukemia model animal
05/18/2000WO2000027182A1 Herbicide resistant rice
05/18/2000WO2000012756A3 Reaction chambers coated with defined concentrations of nucleic acids, method for the production and use thereof
05/18/2000WO2000011190A3 UDP-N-ACETYL GLUCOSAMINYL: β1,4 GALACTOSIDE: β1,3N-ACETYL GLUCOSAMINYL TRANSFERASE (POLYLACTOSAMINYL TYPE)
05/18/2000WO2000009734A3 Methods and compositions for use in spliceosome mediated rna trans-splicing
05/18/2000WO2000009730A3 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
05/18/2000WO2000009727A3 Dna shuffling to produce herbicide selective crops
05/18/2000WO2000009725A3 Method for recovering proteins from the interstitial fluid of plant tissues
1 ... 3243 3244 3245 3246 3247 3248 3249 3250 3251 3252 3253 3254 3255 3256 3257 3258 3259 3260 3261 3262 3263 ... 4023